vs
Side-by-side financial comparison of CIVISTA BANCSHARES, INC. (CIVB) and Prenetics Global Ltd (PRE). Click either name above to swap in a different company.
Prenetics Global Ltd is the larger business by last-quarter revenue ($92.0M vs $47.3M, roughly 1.9× CIVISTA BANCSHARES, INC.).
Civista Bancshares, Inc. is a US-based bank holding company operating primarily across the Midwest region. It provides a full suite of personal and commercial banking services including deposit accounts, mortgage, consumer and commercial lending products, as well as wealth management solutions, serving retail consumers, small and medium-sized local businesses and community client segments.
Prenetics (NASDAQ:PRE) is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer.
CIVB vs PRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2023
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $92.0M |
| Net Profit | $15.0M | — |
| Gross Margin | — | 39.2% |
| Operating Margin | — | — |
| Net Margin | 31.7% | — |
| Revenue YoY | — | — |
| Net Profit YoY | 47.4% | — |
| EPS (diluted) | $0.72 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $47.3M | — | ||
| Q4 25 | $46.3M | — | ||
| Q3 25 | $44.2M | — | ||
| Q2 25 | $41.4M | — | ||
| Q1 25 | $40.6M | — | ||
| Q4 24 | $40.4M | — | ||
| Q3 24 | $39.3M | — | ||
| Q2 24 | $38.1M | — |
| Q1 26 | $15.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $12.8M | — | ||
| Q2 25 | $11.0M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $7.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 31.8% | — | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 31.1% | — | ||
| Q1 25 | 29.4% | — | ||
| Q4 24 | 28.2% | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | 21.2% | — |
| Q1 26 | 31.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 28.9% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | 25.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 21.3% | — | ||
| Q2 24 | 18.5% | — |
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.59 | — | ||
| Q3 25 | $0.68 | — | ||
| Q2 25 | $0.71 | — | ||
| Q1 25 | $0.66 | — | ||
| Q4 24 | $0.62 | — | ||
| Q3 24 | $0.53 | — | ||
| Q2 24 | $0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $553.9M | — |
| Total Assets | $4.3B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $553.9M | — | ||
| Q4 25 | $543.5M | — | ||
| Q3 25 | $499.0M | — | ||
| Q2 25 | $404.1M | — | ||
| Q1 25 | $397.4M | — | ||
| Q4 24 | $388.5M | — | ||
| Q3 24 | $394.4M | — | ||
| Q2 24 | $373.8M | — |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.1B | — | ||
| Q2 24 | $4.0B | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CIVB
| Net Interest Income | $37.8M | 80% |
| Noninterest Income | $9.4M | 20% |
PRE
Segment breakdown not available.
